Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biomedola AB
AB
Active
Org 5568391543
Svargränd 9, 187 42
Täby
General medical practice activities
· NACE 8621
Est. 2011
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
Biomedola AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
781
966
1 167
1 021
1 029
Staff expenses
—
−143
−288
−439
−656
EBITDA
539
743
780
492
283
Depreciation & amort.
−0
—
—
—
—
EBIT
539
743
780
492
283
Net financials
−1
0
37
991
17
Profit before tax
520
656
749
1 496
754
Tax
−111
−138
−162
−131
−165
Net profit
409
518
587
1 364
589
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
4 078
4 516
5 045
6 181
6 120
Equity
2 669
3 003
3 402
4 562
4 943
Long-term debt
0
—
—
—
—
Short-term debt
132
149
209
198
212
Total debt
132
149
209
198
212
Financial ratios
5-year trend
EBITDA margin
27.5%
This company
15.8%
Market median
+74% vs market
2021
2025
Equity ratio
80.8%
This company
38.2%
Market median
+112% vs market
2021
2025
Return on equity
11.9%
This company
18.4%
Market median
+35% vs market
2021
2025
Net profit margin
57.3%
This company
8.1%
Market median
+607% vs market
2021
2025
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
2021
2025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Biomedola AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network